Staphylococcus aureus-Associated Musculoskeletal Infections

Area of Science:

• Infectious Diseases
• Musculoskeletal Health
• Bacteriology

Background:

• Staphylococcus aureus is a significant pathogen causing difficult-to-treat musculoskeletal infections.
• Osteomyelitis due to S. aureus leads to substantial disease burden, including relapses and functional deficits.
• While rare in the general population, S. aureus acute arthritis is more prevalent in individuals with rheumatoid arthritis, presenting a high risk of mortality and disability.

Purpose of the Study:

• To highlight the challenges in managing Staphylococcus aureus-associated musculoskeletal infections.
• To emphasize the need for timely diagnosis and treatment of S. aureus osteomyelitis, acute arthritis, and pyomyositis.
• To underscore the importance of interdisciplinary collaboration for optimal patient outcomes.

Main Methods:

• Review of clinical presentations and management strategies for S. aureus musculoskeletal infections.
• Analysis of disease burden, diagnostic challenges, and treatment outcomes.
• Emphasis on epidemiological variations and recognition of uncommon presentations.

Main Results:

• S. aureus osteomyelitis presents long-term challenges with potential for relapse and functional impairment.
• S. aureus acute arthritis requires urgent intervention due to rapid progression, high mortality, and disability rates.
• S. aureus pyomyositis, though more common in tropical regions, is increasingly reported globally, necessitating physician awareness.

Conclusions:

• Optimal management of S. aureus-associated musculoskeletal infections necessitates a multidisciplinary approach.
• Early recognition and prompt, collaborative treatment are crucial for improving outcomes in patients with S. aureus osteomyelitis, arthritis, and pyomyositis.
• Physicians must remain vigilant for increasingly reported cases of S. aureus pyomyositis in non-tropical regions.